ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,686,000 | +36.9% | 37,280 | +69.6% | 0.10% | +74.6% |
| Q2 2022 | $1,232,000 | -22.3% | 21,979 | -1.5% | 0.06% | -33.7% |
| Q1 2022 | $1,586,000 | -45.8% | 22,307 | -50.3% | 0.09% | -18.3% |
| Q4 2021 | $2,928,000 | +8.9% | 44,868 | +25.2% | 0.11% | -21.6% |
| Q3 2021 | $2,688,000 | -47.2% | 35,826 | -45.1% | 0.14% | -36.5% |
| Q2 2021 | $5,089,000 | +1089.0% | 65,216 | +1148.6% | 0.22% | +812.5% |
| Q1 2021 | $428,000 | -0.9% | 5,223 | +0.1% | 0.02% | -33.3% |
| Q4 2020 | $432,000 | -5.9% | 5,220 | -29.6% | 0.04% | -52.6% |
| Q2 2020 | $459,000 | +53.5% | 7,417 | +58.9% | 0.08% | +111.1% |
| Q1 2020 | $299,000 | -56.5% | 4,668 | -52.9% | 0.04% | -35.7% |
| Q4 2019 | $687,000 | -26.9% | 9,919 | -33.2% | 0.06% | -1.8% |
| Q3 2019 | $940,000 | -53.0% | 14,848 | -53.0% | 0.06% | -67.1% |
| Q2 2019 | $2,000,000 | -6.1% | 31,564 | -13.5% | 0.17% | -46.4% |
| Q1 2019 | $2,130,000 | – | 36,471 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |